PHI with Extradural non-traumatic hemorrhage
How does this condition affect your private health insurance?
Extradural non-traumatic hemorrhage is a rare, spontaneous bleeding occurring in the space between the skull and the dura mater, unrelated to head trauma. Unlike typical epidural hematomas, its etiology is often diverse, including vascular malformations, coagulopathies, tumors, infections, or can be idiopathic. Symptoms, which often develop rapidly, include severe headache, nausea, vomiting, seizures, and focal neurological deficits due to brain compression. Prompt diagnosis via imaging like CT or MRI is crucial. This condition is a medical emergency requiring urgent neurosurgical intervention to evacuate the hematoma and relieve pressure, often followed by management of the underlying cause.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute onset, typically hours to days, requiring immediate medical intervention. If left untreated, rapid deterioration can lead to death within hours to days.
Duration of Illness (Lifetime)
Primarily a one-time acute event if successfully treated. However, if the underlying cause (e.g., vascular malformation) is not fully resolved, there's a risk of recurrence. Recovery period can extend for weeks to months depending on neurological damage.
Cost of Treatment (Initial)
Very high. Involves emergency diagnostics (CT/MRI), neurosurgical intervention (craniotomy), intensive care unit (ICU) stay, and post-operative care, easily ranging from $50,000 to $200,000+.
Cost of Treatment (Lifetime)
High to very high. Includes initial emergency treatment. If there are lasting neurological deficits (e.g., stroke-like symptoms, seizures), long-term rehabilitation, medications, and potential follow-up surgeries significantly increase lifetime costs, potentially exceeding several hundred thousand dollars.
Mortality Rate
High (20-50%) if diagnosis or treatment is delayed. Even with prompt intervention, mortality can be 5-20% depending on hematoma size, location, patient age, and neurological status at presentation.
Risk of Secondary Damages
High (50-80%). Common secondary damages include persistent neurological deficits (e.g., weakness, sensory loss, speech difficulties), seizures, cognitive impairment, headaches, and psychological distress. The extent depends on the severity and duration of brain compression.
Probability of Full Recovery
Low to moderate (20-40%). While some patients make a good recovery, a significant proportion experience residual neurological or cognitive deficits. Complete recovery without any lasting consequences is less common, especially with larger hematomas or delayed treatment.
Underlying Disease Risk
Moderate to high (30-60%). While some cases are idiopathic, many are associated with underlying conditions such as arterial malformations (e.g., dural arteriovenous fistulas), coagulopathies (e.g., thrombocytopenia, anticoagulant use), tumors (e.g., meningioma metastases), or infections (e.g., osteomyelitis of the skull).